Why Is Conduit Pharmaceuticals (CDT) Stock Up 73% Today?

It’s time to dive into the biggest pre-market stock movers as we check out all of the latest news worth reading about on Tuesday morning!

Moving stocks are new agreements, a patent, a public offering and more.

Let’s get into that news below!

Biggest Pre-Market Stock Movers: 10 Top Gainers

• SILO Pharma stock is rocketing more than 69% after securing a new license.
• Conduit Pharmaceuticals shares are soaring over 65% with heavy pre-market trading.
• SciSparc stock is surging more than 39% on a new weight loss patent.
• Meiwu Technology shares are rising over 30% with strong early morning trading.
• Singing Machine stock is increasing more than 25% on a $9 million revenue backlog contract.
• Passage Bio shares are gaining over 18% on clinical trial expansion feedback.
• AEON Biopharma stock is climbing more than 16% with strong pre-market trading.
• Shineco shares are getting an over 12% boost after closing a public offering.
• SMX (Security Matters) S stock is jumping more than 11% following a reverse stock split.
• Biomerica shares are up over 11% this morning.

10 Top Losers

• Autonomix Medical stock is diving more than 18% following a rally yesterday.
• Vince shares are tumbling over 17% without any clear news this morning.
• TuanChe stock is taking a more than 17% beating on Tuesday morning.
• Greenpro Capital shares are sliding over 17% after rising yesterday on a strategic alliance.
• Lottery.com stock is dropping more than 16% on Tuesday.
• Vicinity Motor shares are decreasing over 16% this morning.
• Tantech stock is falling more than 15% despite a lack of news this morning.
• MF International M shares are slipping over 14% on Tuesday morning.
• Cyngn C stock is dropping close to 14% after a recent rally.
• Lixiang Education shares close out our pre-market stock movers down more than 12% today.

On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.

More from InvestorPlace

• AI Breakthroughs: The Next Big Thing to Bet On
• Buy the Top AI Stocks Before the Disinflation Boom
• Apple Intelligence: The Next Frontier in AI Development

Shares of Match Group, Inc. rose sharply in today's pre-market trading.

Starboard Value has taken a keen interest in Match Group. The hedge fund has accumulated a stake of over 6.5% in the online dating company and is advocating for a potential sale if the company's performance does not improve, The Wall Street Journal reported on Monday, citing people familiar with the matter.

Match Group shares jumped 8% to $34.56 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

• Conduit Pharmaceuticals Inc. gained 89.8% to $0.4556 in pre-market trading after declining over 8% on Monday.
• Meiwu Technology Company Limited shares rose 46% to $1.27 in pre-market trading after surging around 15% on Monday.
• AEON Biopharma, Inc. shares rose 17.1% to $2.67 in pre-market trading after jumping around 63% on Monday.
• 36Kr Holdings Inc. rose 11.1% to $0.33 in pre-market trading. 36Kr Holdings said it has entered into a strategic partnership with Zhi-Tech Group to broaden its business expansion and commercialization initiatives.
• ConnectM Technology Solutions Inc. C gained 11% to $2.54 in pre-market trading after dipping 35% on Monday.
• AgEagle Aerial Systems, Inc. shares gained 9.1% to $0.4990 in pre-market trading after declining around 5% on Monday.
• Siebert Financial Corp. shares climbed 8.6% to $1.89 in pre-market trading.
• Opendoor Technologies Inc. shares surged 8.6% to $2.76 in pre-market trading. Opendoor Technologies is expected to report second quarter financial results after the closing bell on Thursday, Aug. 1.
• Chegg, Inc. gained 5.4% to $3.34 in pre-market trading. Morgan Stanley analyst Josh Baer upgraded Chegg from Underweight to Equal-Weight and lowered the price target from $6.5 to $3.25.

Losers

• Greenpro Capital Corp. shares fell 20.5% to $0.9384 in pre-market trading. Greenpro Capital shares surged around 35% on Monday after the company announced that its subsidiary, Green-X, secured over $100 million in digital assets.
• Autonomix Medical, Inc. shares declined 17.4% to $1.14 in pre-market trading. Autonomix shares jumped 130% on Monday after the company entered into an agreement with RF Innovations to license intellectual property for its Apex 6 Radiofrequency Generator.
• American Rebel Holdings, Inc. shares fell 17.4% to $0.5550 in pre-market trading after jumping 29% on Monday.
• Cyngn Inc. C shares fell 15% to $7.80 in pre-market trading after jumping 54% on Monday.
• DatChat, Inc. fell 12.2% to $1.66 in pre-market trading. Shares of DatChat jumped around 78% on Monday possibly after the attempted assassination of former President Donald Trump over the weekend.
• Qualigen Therapeutics, Inc. shares fell 9.7% to $0.3493 in pre-market trading after dipping more than 10% on Monday.
• Vicinity Motor Corp. shares dipped 10.8% to $0.57 in pre-market trading after dipping 10% on Monday.
• Trump Media & Technology Group Corp. shares fell 8.8% to $37.03 in pre-market trading. Trump Media & Technology Group shares jumped over 31% on Monday following the attempted assassination of Donald Trump.
• Anavex Life Sciences Corp. fell 7% to $5.43 in pre-market trading after surging 8% on Monday.
• Grom Social Enterprises, Inc. shares declined 6.5% to $0.40 in pre-market trading after gaining around 10% on Monday.

Now Read This: Top 5 Consumer Stocks That May Explode In Q3

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Conduit Pharmaceuticals is slated to join the Russell 3000 Index at the opening of US markets on July 1, the company said Thursday, citing the preliminary list posted by FTSE Russel.

The inclusion will follow the annual index reconstitution, which is based on market capitalization rankings of US stocks as of April 30, Conduit said.

Shares of the company rose 9.8% in recent Thursday trading.

Vivos Therapeutics shares slumped 35% Thursday premarket, paring Wednesday's rally.

Redhill Biopharma shares declined 27%, erasing Wednesday's gains.

Yoshiharu Global shares tumbled 21%, shaving gains from the previous session.

Conduit Pharmaceuticals shares fell 17%, reversing from the previous session's rally.

Pure Storage shares were 16% lower, a day after the company issued fiscal Q4 and fiscal 2024 revenue guidance that trailed analysts' estimates.

US stocks look set to open Monday's trading session higher as await the start of the two-day policy setting Federal Open Market Committee's meeting Tuesday as well as key earnings reports during the week.

The Dow Jones Industrial Average futures were up 0.61%, S&P 500 futures gained 0.62%, and Nasdaq futures were moving 0.71% higher.

Oil prices were moving sharply lower, with front-month global benchmarks Brent crude and West Texas Intermediate crude falling 1.22% and 1.52% respectively.

In other world markets, Japan's Nikkei closed 0.95% lower, Hong Kong's Hang Seng nudged 0.04% higher, and China's Shanghai Composite gained 0.12%. Meanwhile in Europe's early afternoon session, the UK's FTSE 100 was up 0.80%, while Germany's DAX index and France's CAC were rising 0.45% and 0.62% respectively.

On the winning side, shares of Miromatrix Medical soared 225% in Monday's premarket session after it said earlier Monday that it agreed to be acquired by United Therapeutics for $3.25 per share in cash and an additional $1.75 per share if a clinical development milestone related to Miromatrix's mirokidney kidney product is met by the end of 2025. Conduit Pharmaceuticals shares jumped 50%, after a 10% loss on Friday. Shares of Eargo surged 49% after it said it agreed to be acquired by an affiliate of Patient Square Capital for $2.55 per share in cash. Shares of VYNE Therapeutics rose 47% after reporting a positive effect of VYN202 in preclinical models of psoriasis and rheumatoid arthritis and positive data from a nonsegmental vitiligo phase 1b of VYN201. And shares of SeaStar Medical climbed 17% after it said the US Food and Drug Administration issued an approvable letter for the company's proprietary Selective Cytopheretic Device Pediatric.

On the losing side, shares of Fujian Blue Hat Interactive Entertainment Technology shed 14%, piling on to a 38% loss the previous session. Alzamend Neuro shares dropped 22% after it said Monday that its board approved a one-for-15 reverse stock split. Laird Superfood shares tumbled 20% after a marginal loss Friday. Shares of CommScope lost 22% after reporting lower-than-expected Q3 earnings. And shares of Forbion European Acquisition Corp. fell 17% after jumping 59% on Friday.

US stock futures were trending higher in Monday's premarket session as investors look ahead to the start of the two-day policy setting Federal Open Market Committee's meeting Tuesday as well as key earnings reports during the week.

Dow Jones Industrial Average futures were up 0.6%, S&P 500 futures gained 0.7%, and Nasdaq futures were moving 0.8% higher.

Later Monday morning, investors will be eyeing the Dallas Federal Reserve's Manufacturing Survey, which tracks factory activity in Texas and is used by the Fed as an inflation gauge.

At the conclusion of the FOMC meeting Wednesday afternoon, the Fed is expected to keep interest rates unchanged as it waits for the effects of its previous rate hikes to cool off inflation.

Oil prices were moving lower, with front-month global benchmarks North Sea Brent crude down 1.0% and US West Texas Intermediate crude falling 1.3%.

Shares of Miromatrix Medical soared 225% in Monday's premarket session after it said earlier Monday it has agreed to be acquired by United Therapeutics for $3.25 per share in cash and an additional $1.75 per share if a clinical development milestone related to Miromatrix's mirokidney kidney product is met by the end of 2025. Conduit Pharmaceuticals shares jumped 73%, after a 13% loss on Friday. And shares of VYNE Therapeutics surged 54% after reporting a positive effect of VYN202 in preclinical models of psoriasis and rheumatoid arthritis a d positive data from a nonsegmental vitiligo phase 1b of VYN201.

Meanwhile shares of BIO-key International tumbled 24%, nearly erasing a 29% gain from Friday. Hyperfine shares fell 27%, adding to a 4% loss the previous session. And shares of Laird Superfood dropped 24% after a marginal loss Friday.